Publication | Open Access
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
389
Citations
21
References
2014
Year
Pasireotide LAR demonstrated superior efficacy over octreotide LAR and is a viable new treatment option for acromegaly.
| Year | Citations | |
|---|---|---|
Page 1
Page 1